Savara Inc.
SVRA
$3.17
-$0.01-0.31%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/28/2025
-
Ticker Report
4/26/2025
-
Tickeron - Stocks
4/24/2025
-
Tickeron - Technical Analysis
4/23/2025
-
Tickeron - Stocks
4/22/2025
-
ETF Channel
4/21/2025
-
SeekingAlpha
4/21/2025
-
Seeking Alpha - Long Ideas
4/21/2025
-
MarketBeat
4/17/2025
-
MarketBeat
4/17/2025
-
MarketBeat
4/16/2025
-
Ticker Report
4/13/2025
-
MarketBeat
4/11/2025
-
GuruFocus
4/11/2025
-
GuruFocus
4/11/2025
-
Business Wire
4/9/2025
-
Ticker Report
4/7/2025
-
Business Wire
4/3/2025
-
Simply Wall St
4/3/2025
-
Tickeron - Stocks
4/1/2025
-
Market News Video
3/31/2025
-
MarketBeat
3/29/2025
-
MarketBeat
3/29/2025
-
MarketBeat
3/28/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
512 614 1848
Address
1717 Langhorne Newtown Road
Langhorne, PA 19047
Langhorne, PA 19047
Country
Year Founded
Business Description
Sector
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage...
more